COYA coyatherapeutics.com: יחס מחיר להכנסות חזויות

The forward price-to-sales valuation trend for Coya Therapeutics, Inc. (COYA) demonstrates the impact of cold chain logistics on cell therapy, while 14.90 captures the current value of the indicator. Geopolitical tensions and sanctions are hindering drug certification and international studies. Simultaneously, growing demand for ALS and Alzheimer's disease treatments is driving the search for strategic pharmaceutical partners.
COYA (Coya): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The forward P/S ratio assesses the market value of the business relative to expected revenue, allowing investors to determine the degree of asset overvaluation before funds are actually received. The forward P/S dynamics based on forecasts reflect the sensitivity of the capitalization to the efficiency of biomaterial logistics, as any disruptions in the transportation of molecules for Coya Therapeutics (COYA) directly reduce the probability of drug commercialization and expected revenues.